Searchable abstracts of presentations at key conferences in endocrinology

ea0032p82 | Bone and Osteoporosis | ECE2013

The value of PRP/PRF in the treatment of bisphosphonates-induced maxillary osteonecrosis: preliminary study

Costan Victor-Vlad , Ciofu Mihai Liviu , Popescu Eugenia , Vulpoi Carmen

Background: Intravenous bisphosphonates treatment brings real benefits to patients with bone metastases. Unfortunately, this treatment sometimes has a difficult to treat complication, often disabling for the patients – the osteonecrosis of the jaws. A new approach in the management of this complication is the use of platelet rich plasma (PRP).Patients and methods: Five patients aged between 62 and 72 years old (three men and two women) were included...